סיטגליפטין - Sitagliptin

סיטגליפטין - Sitagliptin
התוויות	Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: Januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. Januvia has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januvia.

דרך מתן

סיטגליפטין - Sitagliptin
שמות מסחריים	®JANUVIA


קבוצה פרמקולוגית (ATC)	"DIPEPTIDYL PEPTIDASE 4 ( DPP - 4 ) INHIBITORS"
שם גנרי	"סיטגליפטין" (קישור לדף התרופה במאגר משרד הבריאות)
סל הבריאות	לא כלול
התוויות	Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: Januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. Januvia has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januvia.
קיים גם בתכשירים	®JANUET
שם יצרן	MERCK & CO., INC.,USA
שם בעל הרישום	MERCK SHARP & DOHME ISRAEL LTD